- Home
- BIVI vs TNON Comparison
BIVI vs TNON Comparison
Compare BIVI & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- TNON
- Stock Information
- Founded
- BIVI 2013
- TNON 2012
- Country
- BIVI United States
- TNON United States
- Employees
- BIVI N/A
- TNON N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- TNON Medical Specialities
- Sector
- BIVI Health Care
- TNON Health Care
- Exchange
- BIVI Nasdaq
- TNON Nasdaq
- Market Cap
- BIVI 14.2M
- TNON 11.5M
- IPO Year
- BIVI N/A
- TNON 2022
- Fundamental
- Price
- BIVI $1.50
- TNON $1.15
- Analyst Decision
- BIVI
- TNON Strong Buy
- Analyst Count
- BIVI 0
- TNON 2
- Target Price
- BIVI N/A
- TNON $5.50
- AVG Volume (30 Days)
- BIVI 119.4K
- TNON 1.0M
- Earning Date
- BIVI 11-11-2025
- TNON 11-13-2025
- Dividend Yield
- BIVI N/A
- TNON N/A
- EPS Growth
- BIVI N/A
- TNON N/A
- EPS
- BIVI N/A
- TNON N/A
- Revenue
- BIVI N/A
- TNON $2,947,000.00
- Revenue This Year
- BIVI N/A
- TNON $17.85
- Revenue Next Year
- BIVI N/A
- TNON $85.60
- P/E Ratio
- BIVI N/A
- TNON N/A
- Revenue Growth
- BIVI N/A
- TNON N/A
- 52 Week Low
- BIVI $1.42
- TNON $0.85
- 52 Week High
- BIVI $38.50
- TNON $5.85
- Technical
- Relative Strength Index (RSI)
- BIVI 29.30
- TNON 42.76
- Support Level
- BIVI $1.83
- TNON $1.15
- Resistance Level
- BIVI $1.80
- TNON $1.26
- Average True Range (ATR)
- BIVI 0.10
- TNON 0.07
- MACD
- BIVI -0.03
- TNON -0.01
- Stochastic Oscillator
- BIVI 14.79
- TNON 12.12
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.